Axis Wealth Partners LLC decreased its holdings in shares of Xylem Inc. (NYSE:XYL – Free Report) by 27.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,555 shares of the industrial products company’s stock after selling 5,151 shares during the quarter. Axis Wealth Partners LLC’s holdings in Xylem were worth $1,620,000 at the end of the most recent quarter.
Several other institutional investors also recently added to or reduced their stakes in the business. Knuff & Co LLC bought a new stake in shares of Xylem in the third quarter valued at approximately $27,000. Wexford Capital LP bought a new position in Xylem during the third quarter worth $27,000. Commonwealth Retirement Investments LLC bought a new stake in Xylem in the 4th quarter valued at $27,000. Ramirez Asset Management Inc. grew its position in Xylem by 100.0% in the 3rd quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock worth $30,000 after purchasing an additional 100 shares during the last quarter. Finally, Board of the Pension Protection Fund acquired a new stake in Xylem in the 4th quarter worth $27,000. 87.96% of the stock is owned by institutional investors.
Analyst Ratings Changes
XYL has been the subject of a number of research analyst reports. Jefferies Financial Group raised shares of Xylem from a “hold” rating to a “buy” rating and upped their price objective for the company from $130.00 to $140.00 in a research report on Thursday, June 25th. CLSA raised Xylem to a “hold” rating in a research report on Thursday, June 25th. UBS Group boosted their price target on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Oppenheimer cut their price target on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a report on Wednesday, April 29th. Finally, Barclays reduced their price objective on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research report on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $153.54.
Xylem Stock Performance
NYSE:XYL opened at $118.22 on Friday. Xylem Inc. has a 12-month low of $105.29 and a 12-month high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $28.10 billion, a PE ratio of 29.41, a price-to-earnings-growth ratio of 1.67 and a beta of 1.03. The firm has a 50-day moving average price of $112.72 and a 200 day moving average price of $124.71.
Xylem (NYSE:XYL – Get Free Report) last released its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The company had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.11 billion. During the same period in the previous year, the business earned $1.03 earnings per share. The company’s quarterly revenue was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Research analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were paid a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. The ex-dividend date was Thursday, May 28th. Xylem’s payout ratio is currently 42.79%.
Insider Activity
In other news, Director Jerome A. Peribere bought 1,210 shares of the stock in a transaction dated Monday, May 4th. The shares were acquired at an average price of $116.61 per share, with a total value of $141,098.10. Following the acquisition, the director owned 27,209 shares in the company, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their position. The SEC filing for this sale provides additional information. 0.32% of the stock is currently owned by corporate insiders.
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Further Reading
- Five stocks we like better than Xylem
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
